Does BEVACIZUMAB Cause Thrombotic microangiopathy? 310 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 310 reports of Thrombotic microangiopathy have been filed in association with BEVACIZUMAB (JOBEVNE). This represents 0.4% of all adverse event reports for BEVACIZUMAB.
310
Reports of Thrombotic microangiopathy with BEVACIZUMAB
0.4%
of all BEVACIZUMAB reports
12
Deaths
127
Hospitalizations
How Dangerous Is Thrombotic microangiopathy From BEVACIZUMAB?
Of the 310 reports, 12 (3.9%) resulted in death, 127 (41.0%) required hospitalization, and 22 (7.1%) were considered life-threatening.
Is Thrombotic microangiopathy Listed in the Official Label?
Yes, Thrombotic microangiopathy is listed as a known adverse reaction in the official FDA drug label for BEVACIZUMAB.
What Other Side Effects Does BEVACIZUMAB Cause?
Off label use (12,094)
Death (8,493)
Diarrhoea (4,911)
Disease progression (4,653)
Fatigue (4,572)
Nausea (4,357)
Hypertension (4,309)
Anaemia (3,221)
Vomiting (3,193)
Neutropenia (2,875)
What Other Drugs Cause Thrombotic microangiopathy?
TACROLIMUS (1,982)
MYCOPHENOLATE MOFETIL (820)
CYCLOSPORINE (724)
GEMCITABINE (648)
ECULIZUMAB (636)
CYCLOPHOSPHAMIDE (602)
FLUDARABINE (480)
METHOTREXATE (447)
CARFILZOMIB (350)
METHYLPREDNISOLONE (345)
Which BEVACIZUMAB Alternatives Have Lower Thrombotic microangiopathy Risk?
BEVACIZUMAB vs BEVACIZUMAB-AWWB
BEVACIZUMAB vs BEVACIZUMAB-BVZR
BEVACIZUMAB vs BEVACIZUMAB-MALY
BEVACIZUMAB vs BEXAROTENE
BEVACIZUMAB vs BEYAZ